Ambea AB (publ)

0RNX.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0RNX.L stands at 4.72B. In comparison, MDC.L has a market cap of 3.69B. Regarding current trading prices, 0RNX.L is priced at $50.29, while MDC.L trades at $501.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0RNX.L currently has a P/E ratio of 18.50, whereas MDC.L's P/E ratio is 21.78. In terms of profitability, 0RNX.L's ROE is +0.13%, compared to MDC.L's ROE of +0.05%. Regarding short-term risk, 0RNX.L is more volatile compared to MDC.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RNX.L.

0RNX.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0RNX.L stands at 4.72B. In comparison, 0NEX.L has a market cap of 3.65B. Regarding current trading prices, 0RNX.L is priced at $50.29, while 0NEX.L trades at $22.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0RNX.L currently has a P/E ratio of 18.50, whereas 0NEX.L's P/E ratio is N/A. In terms of profitability, 0RNX.L's ROE is +0.13%, compared to 0NEX.L's ROE of N/A. Regarding short-term risk, 0RNX.L is more volatile compared to 0NEX.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RNX.L.

0RNX.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0RNX.L stands at 4.72B. In comparison, 0RF7.L has a market cap of 2.55B. Regarding current trading prices, 0RNX.L is priced at $50.29, while 0RF7.L trades at $48.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0RNX.L currently has a P/E ratio of 18.50, whereas 0RF7.L's P/E ratio is 9.61. In terms of profitability, 0RNX.L's ROE is +0.13%, compared to 0RF7.L's ROE of +0.01%. Regarding short-term risk, 0RNX.L is less volatile compared to 0RF7.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RNX.L.

0RNX.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0RNX.L stands at 4.72B. In comparison, 0OPS.L has a market cap of 1.17B. Regarding current trading prices, 0RNX.L is priced at $50.29, while 0OPS.L trades at $14.47.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0RNX.L currently has a P/E ratio of 18.50, whereas 0OPS.L's P/E ratio is 19.77. In terms of profitability, 0RNX.L's ROE is +0.13%, compared to 0OPS.L's ROE of -0.03%. Regarding short-term risk, 0RNX.L is more volatile compared to 0OPS.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RNX.L.

0RNX.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0RNX.L stands at 4.72B. In comparison, SPI.L has a market cap of 818.83M. Regarding current trading prices, 0RNX.L is priced at $50.29, while SPI.L trades at $203.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0RNX.L currently has a P/E ratio of 18.50, whereas SPI.L's P/E ratio is 33.92. In terms of profitability, 0RNX.L's ROE is +0.13%, compared to SPI.L's ROE of +0.03%. Regarding short-term risk, 0RNX.L is less volatile compared to SPI.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RNX.L.

0RNX.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0RNX.L stands at 4.72B. In comparison, OPT.L has a market cap of 173.11M. Regarding current trading prices, 0RNX.L is priced at $50.29, while OPT.L trades at $195.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0RNX.L currently has a P/E ratio of 18.50, whereas OPT.L's P/E ratio is -97.50. In terms of profitability, 0RNX.L's ROE is +0.13%, compared to OPT.L's ROE of N/A. Regarding short-term risk, 0RNX.L is less volatile compared to OPT.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RNX.L.

0RNX.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0RNX.L stands at 4.72B. In comparison, MDMG.L has a market cap of 52.59M. Regarding current trading prices, 0RNX.L is priced at $50.29, while MDMG.L trades at $0.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0RNX.L currently has a P/E ratio of 18.50, whereas MDMG.L's P/E ratio is 0.96. In terms of profitability, 0RNX.L's ROE is +0.13%, compared to MDMG.L's ROE of +0.18%. Regarding short-term risk, 0RNX.L is more volatile compared to MDMG.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RNX.L.

0RNX.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0RNX.L stands at 4.72B. In comparison, TLY.L has a market cap of 3.05M. Regarding current trading prices, 0RNX.L is priced at $50.29, while TLY.L trades at $1.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0RNX.L currently has a P/E ratio of 18.50, whereas TLY.L's P/E ratio is -1.55. In terms of profitability, 0RNX.L's ROE is +0.13%, compared to TLY.L's ROE of -0.06%. Regarding short-term risk, 0RNX.L is less volatile compared to TLY.L. This indicates potentially lower risk in terms of short-term price fluctuations for 0RNX.L.

0RNX.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0RNX.L stands at 4.72B. In comparison, UDG.L comparison data is unavailable. Regarding current trading prices, 0RNX.L is priced at $50.29, while UDG.L trades at $1,079.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0RNX.L currently has a P/E ratio of 18.50, whereas UDG.L's P/E ratio is 0.42. In terms of profitability, 0RNX.L's ROE is +0.13%, compared to UDG.L's ROE of +0.10%. Regarding short-term risk, 0RNX.L is more volatile compared to UDG.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RNX.L.

0RNX.L plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, 0RNX.L stands at 4.72B. In comparison, CTH.L comparison data is unavailable. Regarding current trading prices, 0RNX.L is priced at $50.29, while CTH.L trades at $750.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

0RNX.L currently has a P/E ratio of 18.50, whereas CTH.L's P/E ratio is 107.14. In terms of profitability, 0RNX.L's ROE is +0.13%, compared to CTH.L's ROE of +0.09%. Regarding short-term risk, 0RNX.L is more volatile compared to CTH.L. This indicates potentially higher risk in terms of short-term price fluctuations for 0RNX.L.